Tag: GLP-1 receptor agonists

A pioneering study from the Fralin Biomedical Research Institute at Virginia Tech Carilion (VTC) sheds new light on the potential ...

In a groundbreaking synthesis of current clinical evidence, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for diabetes management, are ...

There has been concern that common diabetes drugs could increase the risk of suicide and self-harm. In a new study, ...